We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs

News   Feb 06, 2012

 
DiscoveRx Corporation Continues to Innovate with Solutions for Epigenetic Drug Discovery Programs
 
 
Advertisement
 

RELATED ARTICLES

Structural Cells Multi-task To Engage in Immune Response

News

Analyzing epigenetic and transcriptional regulation in structural cells, researchers found widespread activity of immune genes, suggesting that structural cells are deeply involved in the body’s response to pathogens.

READ MORE

Asthma Drug Salbutamol Inhibits Tau Filament Formation In Vitro

News

A new study suggests that the common asthma drug called salbutamol may offer potential as a treatment for Alzheimer’s disease. Extensive analytical in vitro experiments show that salbutamol is effective at reducing the accumulation of insoluble fibres of the tau protein – which is found in the brains of people with Alzheimer’s disease.

READ MORE

Switching Immune Cells From “Protect” to “Attack” Mode To Treat Prostate Cancer

News

Researchers found that immune cells called macrophages, which are typically found in prostate cancer tumors to help promote growth, can be rewired to attack the disease using therapeutics.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE